Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Generics Office To Be Managed By Relative Unknown

This article was originally published in The Pink Sheet Daily

Executive Summary

Director Uhl’s medical leave puts bioequivalence office head John Peters in the limelight.


Related Content

FDA Generic Office Director Uhl Returns From Medical Leave
GDUFA II Negotiations: Let the Saber-Rattling Begin
ANDA Approval Whiplash: Strong April Follows Terrible March
ANDA Time To Approval, First Action Curves Need To Bend
GDUFA II? Mylan Lawyer Questions User Fee Law’s Future Absent FDA Progress
Drug Shortage Prevention Could Be Funded Through GDUFA
FDA Generics Office Gets Third Director In Three Workdays; Uhl Brings Policy, Pharmacology Experience
FDA's Buehler To Join Teva
FDA's Generic Drugs Office Faces Transition As Director Buehler Departs





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts